Spots Global Cancer Trial Database for human papillomavirus
Every month we try and update this database with for human papillomavirus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine | NCT00501137 | Cervical Cancer Genital Warts | HPV (Human Papi... | 9 Years - 26 Years | University of British Columbia | |
| Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV | NCT05266898 | Papillomavirus ... Human Immunodef... Papillomavirus ... Serology Cervical Intrae... Anal Intraepith... Oral Cavity Inf... | Human papilloma... | 18 Years - 45 Years | Louisiana State University Health Sciences Center in New Orleans | |
| Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley | NCT02714439 | Malignant Neopl... | Proflavine High-Resolution... | 21 Years - 65 Years | The University of Texas Medical Branch, Galveston | |
| Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females | NCT02740790 | Human Papilloma... | HPV vaccine Placebo | 9 Years - 45 Years | Shanghai Zerun Biotechnology Co.,Ltd | |
| Lubricant Investigation in Men to Inhibit Transmission of HPV Infection | NCT02354144 | Human Papilloma... | Carrageenan-bas... Control gel | 18 Years - | McGill University | |
| HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL | NCT03947775 | Anal Intraepith... Anal Cancer Human Papilloma... | 9-valent HPV va... | 18 Years - | University Health Network, Toronto | |
| Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females | NCT01101542 | Infections, Pap... | Cervarix. Data collection | 10 Years - 25 Years | GlaxoSmithKline | |
| Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening | NCT04746872 | Human Papilloma... | Alinity m HR HP... | 25 Years - | Abbott Molecular | |
| The Correlation Between the Haplotype of Human Leukocyte Antigen (HLA) and Human Papillomavirus | NCT00154479 | Cancer of Cervi... | 18 Years - 80 Years | National Taiwan University Hospital | ||
| Serum Galectin-3 as a Marker of Human Papillomavirus Infection | NCT06005389 | Human Papilloma... | cryotherapy serum Galectin-... | 18 Years - 60 Years | Assiut University | |
| Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal | NCT01845779 | Metastatic Anal... Human Papilloma... | DCF regimen | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Telehealth & HPV Self-Collection | NCT05089825 | Gynecologic Can... | Receive routine... Telehealth-base... | 25 Years - 85 Years | OHSU Knight Cancer Institute | |
| The Organ Transplant Recipient HPV and Skin Cancer Study | NCT05284877 | Solid Organ Tra... Skin Cancer Skin Dysplasia HPV Infection Cervical Intrae... Cervical Cancer HPV-Related Mal... | No intervention | 18 Years - | Bispebjerg Hospital | |
| Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil | NCT00524745 | Dose Schedule S... | Biological: qua... | 11 Years - 13 Years | PATH | |
| Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) | NCT05026138 | Human Papilloma... | 3 Years - | National Institutes of Health Clinical Center (CC) | ||
| Natural History of HPV Infection in Men: The HIM Study | NCT00786760 | Human Papilloma... | Cohort: 3000 me... Pilot study: 15... | 18 Years - 70 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females | NCT02740790 | Human Papilloma... | HPV vaccine Placebo | 9 Years - 45 Years | Shanghai Zerun Biotechnology Co.,Ltd | |
| A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age | NCT05496231 | Cervical Intrae... | HPV9 High formu... HPV9 Medium for... HPV9 Low formul... Gardasil 9 | 16 Years - 26 Years | GlaxoSmithKline | |
| Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination | NCT02003508 | Human Papilloma... | 17 Years - 19 Years | The Alfred | ||
| Home-based Cervical Cancer Screening Project | NCT06166420 | Cervical Cancer | Experimental Active comparat... | 30 Years - 49 Years | University Hospital, Geneva | |
| Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time | NCT01342978 | Oropharyngeal C... Human Papilloma... | 18 Years - | Johns Hopkins Bloomberg School of Public Health | ||
| Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study | NCT02323997 | Cervical Cancer | 18 Years - | University of Bern | ||
| E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers | NCT05686226 | Cervical Cancer Throat Cancer Oropharynx Canc... Anal Cancer Vulva Cancer Vaginal Cancer Penile Cancer Metastatic Canc... HPV-Related Mal... HPV-Related Car... HPV-Related Cer... HPV-Related Squ... HPV-Related Ade... HPV Positive Or... HPV-Associated ... HPV-Related Ade... HPV-Related End... HPV-Related Ana... HPV-Related Pen... HPV-Related Vul... HPV Positive Re... | E7 TCR-T cells | 18 Years - | Rutgers, The State University of New Jersey | |
| Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients | NCT02632344 | Recurrent Respi... | Pembrolizumab | 12 Years - | Massachusetts General Hospital | |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand | NCT00849381 | Infections, Pap... | GSK580299, GSK ... | 26 Years - | GlaxoSmithKline | |
| Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer | NCT04572100 | Oropharyngeal S... | Transoral Robot... Chemotherapy an... Chemotherapy an... Paclitaxel Carboplatin | 18 Years - | University of Chicago | |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | NCT04708470 | Oropharyngeal C... Neck Cancer Human Papilloma... HPV Anal Cancer Cervical Cancer Penile Cancer Vulvar Cancer Vaginal Cancer Colon Cancer | Bintrafusp Alfa NHS-IL12 Entinostat | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital) | NCT01159834 | Human Papilloma... Infection | 10 Years - 16 Years | Barretos Cancer Hospital | ||
| Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana | NCT03345875 | Human Papilloma... Cervical Cancer | HPV self collec... | 30 Years - 49 Years | Jhpiego | |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand | NCT00849381 | Infections, Pap... | GSK580299, GSK ... | 26 Years - | GlaxoSmithKline | |
| A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) | NCT05814549 | Oropharyngeal C... HPV-Related Car... HPV Positive Or... | NavDx | 45 Years - | Memorial Sloan Kettering Cancer Center | |
| Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women | NCT02005510 | Cervical Cancer | Mailed in-home ... Usual care | 30 Years - 64 Years | University of Washington | |
| A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) | NCT05814549 | Oropharyngeal C... HPV-Related Car... HPV Positive Or... | NavDx | 45 Years - | Memorial Sloan Kettering Cancer Center | |
| Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) | NCT00365443 | Cervical Cancer Condylomata Acu... | V502 | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Accuracy of Portable Colposcopy and HPV Genotypes Among HIV+ Women | NCT02338141 | Cervical Cancer Human Papilloma... Human Immunodef... | Portable colpos... Conventional co... | 25 Years - 60 Years | Duke University | |
| Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection | NCT03548740 | Papillomavirus ... | Human Papilloma... | 25 Years - 50 Years | Peking Union Medical College Hospital | |
| The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan | NCT05522881 | Oropharyngeal S... | 20 Years - | National Health Research Institutes, Taiwan | ||
| Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions | NCT00154583 | Cervical Cancer | 18 Years - 80 Years | National Taiwan University Hospital | ||
| Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers | NCT01087164 | Human Papilloma... | Compliance Message sidedne... | 11 Years - 15 Years | Indiana University | |
| A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening | NCT01058148 | Cervical Intrae... Human Papilloma... | 26 Years - 65 Years | National Institutes of Health Clinical Center (CC) | ||
| An HPV Vaccine Provider Intervention in Safety Net Clinics | NCT02808832 | Human Papilloma... Uterine Cervica... | Educational mat... | 9 Years - | Meharry Medical College | |
| Cervical And Self-Sample In Screening Study | NCT02397252 | Cervical Cancer Intraepithelial... | Eve Medical sel... cobas® PCR Fema... Physician-colle... | - | McGill University | |
| Alternate Dosing Schedules Study for HPV Vaccine (ADS) | NCT02280642 | Cervical Cancer Genital Warts | Both 2nd and 3r... 2nd dose late a... 2nd dose on tim... Both doses late | 9 Years - 18 Years | Duke University | |
| Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions | NCT03197025 | Human Papilloma... HPV-16 High Grade Squa... | Aldesleukin E6 T Cell Recep... | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | |
| Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL | NCT02576561 | Human Papilloma... High-Grade Squa... | TVGV-1 GPI-0100 Placebo | 18 Years - 55 Years | THEVAX Genetics Vaccine | |
| Recurrence in High-grade Lesions After Conization | NCT02540421 | Cervical Intrae... | 18 Years - | Faculdade de Medicina do ABC | ||
| Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer | NCT01117389 | Human Papilloma... | 9 Years - 26 Years | St. Jude Children's Research Hospital | ||
| Cervical Cancer Early Endpoints and Determinants | NCT00339989 | Cervical Cancer Cervical Intrae... Neoplasia CIN | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions | NCT03226470 | Human Papilloma... | T512 | 18 Years - 50 Years | Huazhong University of Science and Technology | |
| Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women | NCT01366742 | Human Papilloma... CIN 2 CIN 3 | 13 Years - 22 Years | University of California, Los Angeles | ||
| Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls | NCT01381575 | Infections, Pap... | GSK Biologicals... | 9 Years - 25 Years | GlaxoSmithKline | |
| Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand | NCT01328028 | Cervical Cancer | Testing of arch... Data collection | 18 Years - | GlaxoSmithKline | |
| Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix | NCT02346227 | Uterine Cervica... Papillomavirus ... | AV2 Placebo | 25 Years - | Universiteit Antwerpen | |
| Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal | NCT01845779 | Metastatic Anal... Human Papilloma... | DCF regimen | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer | NCT01207999 | Infections, Pap... Cervical Cancer | Collection of c... Data collection | 21 Years - | GlaxoSmithKline | |
| P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC | NCT03077243 | Carcinoma, Squa... Head and Neck N... Oropharyngeal N... | Intensity Modul... Cisplatin (or a... Assessment for ... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Sexually Transmitted Infections Among African American Women Who Have Sex With Women | NCT01043081 | Sexually Transm... HIV Infections | 18 Years - | University of Mississippi Medical Center | ||
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand | NCT00849381 | Infections, Pap... | GSK580299, GSK ... | 26 Years - | GlaxoSmithKline | |
| PApillomavirus in REnal Transplant Patient | NCT02845739 | Papillomavirus ... | Kidney transpla... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | NCT04708470 | Oropharyngeal C... Neck Cancer Human Papilloma... HPV Anal Cancer Cervical Cancer Penile Cancer Vulvar Cancer Vaginal Cancer Colon Cancer | Bintrafusp Alfa NHS-IL12 Entinostat | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand | NCT01328028 | Cervical Cancer | Testing of arch... Data collection | 18 Years - | GlaxoSmithKline | |
| A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study | NCT03355820 | Cervical Intrae... | Blood sampling ... | 17 Years - | GlaxoSmithKline | |
| MR Metabolic Biomarkers for Cervical Cancer | NCT01874548 | Uterine Cervica... | 20 Years - 80 Years | Chang Gung Memorial Hospital | ||
| Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls | NCT01381575 | Infections, Pap... | GSK Biologicals... | 9 Years - 25 Years | GlaxoSmithKline | |
| Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia | NCT01213459 | Infections, Pap... Cervical Cancer | Cervical sample... Data collection | 15 Years - | GlaxoSmithKline | |
| Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana | NCT03345875 | Human Papilloma... Cervical Cancer | HPV self collec... | 30 Years - 49 Years | Jhpiego | |
| The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru | NCT01338051 | Cervical Intrae... Cervical Cancer Cervical Neopla... Cervical Dyspla... Human Papilloma... | Gardasil | 30 Years - 45 Years | Preventive Oncology International, Inc. | |
| Genital HPV Infections Before and After Renal Transplantation | NCT01717443 | Human Papilloma... | 18 Years - | University Medical Center Nijmegen | ||
| The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial) | NCT05419089 | HPV-positive Or... | Robotic surgery | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3 | NCT02651883 | Cervical Cancer Uterine Cervica... Human Papilloma... | Screening invit... Self-collection... | 25 Years - 64 Years | UNC Lineberger Comprehensive Cancer Center | |
| Cryotherapy for Human Papillomavirus Clearance in Biopsy-confirmed Cervical Low-grade Squamous Intraepithelial Lesions | NCT00566579 | Human Papilloma... | Cryotherapy | 30 Years - | Khon Kaen University | |
| Long-Term Follow-Up of HPV FOCAL Participants | NCT04185389 | Cervical Cancer | HPV and cytolog... | 30 Years - 69 Years | University of British Columbia | |
| Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) | NCT05672927 | Immunization HPV Infection Human Papilloma... | 9-valent HPV va... 9-valent HPV va... | 27 Years - 45 Years | The University of Texas Medical Branch, Galveston | |
| Molecular Signatures of HPV+ ORL Cancers (OROPAP) | NCT04189003 | Oropharyngeal C... Human Papilloma... | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US | NCT00799825 | Infections, Pap... | GSK Biological'... | 18 Years - | GlaxoSmithKline | |
| Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL | NCT02576561 | Human Papilloma... High-Grade Squa... | TVGV-1 GPI-0100 Placebo | 18 Years - 55 Years | THEVAX Genetics Vaccine | |
| 102 Annual Pap Smear Screening Database Maintenance Project | NCT02063152 | Cancer Human Papilloma... | 20 Years - 130 Years | National Taiwan University Hospital | ||
| Human Papillomavirus Epidemiology in Nigeria | NCT00804466 | Human Papilloma... Cervical Intrae... Human Papilloma... Uterine Cervica... | OncoE6 EVA System | 30 Years - 49 Years | National Institutes of Health Clinical Center (CC) | |
| Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring | NCT05774561 | Cervical Cancer Cervical Dyspla... Oropharyngeal C... Human Papilloma... | Arm A - Diagnos... Arm B - Diagnos... | 18 Years - 99 Years | The Institute of Molecular and Translational Medicine, Czech Republic | |
| Sexually Transmitted Infections Among African American Women Who Have Sex With Women | NCT01043081 | Sexually Transm... HIV Infections | 18 Years - | University of Mississippi Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
